107 related articles for article (PubMed ID: 16547138)
1. CD4+ regulatory T cell responses induced by T cell vaccination in patients with multiple sclerosis.
Hong J; Zang YC; Nie H; Zhang JZ
Proc Natl Acad Sci U S A; 2006 Mar; 103(13):5024-9. PubMed ID: 16547138
[TBL] [Abstract][Full Text] [Related]
2. In-vitro generation and characterisation of murine CD4+CD25+ regulatory T cells with indirect allospecificity.
Tsang J; Jiang S; Tanriver Y; Leung E; Lombardi G; Lechler RI
Int Immunopharmacol; 2006 Dec; 6(13-14):1883-8. PubMed ID: 17161341
[TBL] [Abstract][Full Text] [Related]
3. Induction of CD4+CD25+ regulatory T cells by copolymer-I through activation of transcription factor Foxp3.
Hong J; Li N; Zhang X; Zheng B; Zhang JZ
Proc Natl Acad Sci U S A; 2005 May; 102(18):6449-54. PubMed ID: 15851684
[TBL] [Abstract][Full Text] [Related]
4. The CD4(+) T-cell response of melanoma patients to a MAGE-A3 peptide vaccine involves potential regulatory T cells.
François V; Ottaviani S; Renkvist N; Stockis J; Schuler G; Thielemans K; Colau D; Marchand M; Boon T; Lucas S; van der Bruggen P
Cancer Res; 2009 May; 69(10):4335-45. PubMed ID: 19435913
[TBL] [Abstract][Full Text] [Related]
5. FoxP3(+)CD4(+)CD25(+) T cells with regulatory properties can be cultured from colonic mucosa of patients with Crohn's disease.
Kelsen J; Agnholt J; Hoffmann HJ; Rømer JL; Hvas CL; Dahlerup JF
Clin Exp Immunol; 2005 Sep; 141(3):549-57. PubMed ID: 16045746
[TBL] [Abstract][Full Text] [Related]
6. Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T cells.
Yagi H; Nomura T; Nakamura K; Yamazaki S; Kitawaki T; Hori S; Maeda M; Onodera M; Uchiyama T; Fujii S; Sakaguchi S
Int Immunol; 2004 Nov; 16(11):1643-56. PubMed ID: 15466453
[TBL] [Abstract][Full Text] [Related]
7. Th2 immune regulation induced by T cell vaccination in patients with multiple sclerosis.
Zang YC; Hong J; Tejada-Simon MV; Li S; Rivera VM; Killian JM; Zhang JZ
Eur J Immunol; 2000 Mar; 30(3):908-13. PubMed ID: 10741408
[TBL] [Abstract][Full Text] [Related]
8. Secondary progressive in contrast to relapsing-remitting multiple sclerosis patients show a normal CD4+CD25+ regulatory T-cell function and FOXP3 expression.
Venken K; Hellings N; Hensen K; Rummens JL; Medaer R; D'hooghe MB; Dubois B; Raus J; Stinissen P
J Neurosci Res; 2006 Jun; 83(8):1432-46. PubMed ID: 16583400
[TBL] [Abstract][Full Text] [Related]
9. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells.
Fontenot JD; Gavin MA; Rudensky AY
Nat Immunol; 2003 Apr; 4(4):330-6. PubMed ID: 12612578
[TBL] [Abstract][Full Text] [Related]
10. CD4+ CD25+ FOXP3+ regulatory T cells from human thymus and cord blood suppress antigen-specific T cell responses.
Wing K; Larsson P; Sandström K; Lundin SB; Suri-Payer E; Rudin A
Immunology; 2005 Aug; 115(4):516-25. PubMed ID: 16011520
[TBL] [Abstract][Full Text] [Related]
11. CD4(+) CD25(+) FoxP3(+) T regulatory cells in subjects responsive or unresponsive to hepatitis B vaccination.
Li J; Tan D; Liu H; Li K
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Nov; 36(11):1046-51. PubMed ID: 22169715
[TBL] [Abstract][Full Text] [Related]
12. CD39+Foxp3+ regulatory T Cells suppress pathogenic Th17 cells and are impaired in multiple sclerosis.
Fletcher JM; Lonergan R; Costelloe L; Kinsella K; Moran B; O'Farrelly C; Tubridy N; Mills KH
J Immunol; 2009 Dec; 183(11):7602-10. PubMed ID: 19917691
[TBL] [Abstract][Full Text] [Related]
13. A novel nanoparticle containing MOG peptide with BTLA induces T cell tolerance and prevents multiple sclerosis.
Yuan B; Zhao L; Fu F; Liu Y; Lin C; Wu X; Shen H; Yang Z
Mol Immunol; 2014 Feb; 57(2):93-9. PubMed ID: 24084097
[TBL] [Abstract][Full Text] [Related]
14. Role of IFN-gamma in induction of Foxp3 and conversion of CD4+ CD25- T cells to CD4+ Tregs.
Wang Z; Hong J; Sun W; Xu G; Li N; Chen X; Liu A; Xu L; Sun B; Zhang JZ
J Clin Invest; 2006 Sep; 116(9):2434-41. PubMed ID: 16906223
[TBL] [Abstract][Full Text] [Related]
15. Daily subcutaneous injections of peptide induce CD4+ CD25+ T regulatory cells.
Dahlberg PE; Schartner JM; Timmel A; Seroogy CM
Clin Exp Immunol; 2007 Aug; 149(2):226-34. PubMed ID: 17490400
[TBL] [Abstract][Full Text] [Related]
16. Interferon-beta enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis.
Schreiner B; Mitsdoerffer M; Kieseier BC; Chen L; Hartung HP; Weller M; Wiendl H
J Neuroimmunol; 2004 Oct; 155(1-2):172-82. PubMed ID: 15342209
[TBL] [Abstract][Full Text] [Related]
17. Origin and T cell receptor diversity of Foxp3+CD4+CD25+ T cells.
Pacholczyk R; Ignatowicz H; Kraj P; Ignatowicz L
Immunity; 2006 Aug; 25(2):249-59. PubMed ID: 16879995
[TBL] [Abstract][Full Text] [Related]
18. Cellular and humoral immune responses against autoreactive T cells in multiple sclerosis patients after T cell vaccination.
Hermans G; Denzer U; Lohse A; Raus J; Stinissen P
J Autoimmun; 1999 Sep; 13(2):233-46. PubMed ID: 10479392
[TBL] [Abstract][Full Text] [Related]
19. Multiple sclerosis associated genetic variants of CD226 impair regulatory T cell function.
Piédavent-Salomon M; Willing A; Engler JB; Steinbach K; Bauer S; Eggert B; Ufer F; Kursawe N; Wehrmann S; Jäger J; Reinhardt S; Friese MA
Brain; 2015 Nov; 138(Pt 11):3263-74. PubMed ID: 26359290
[TBL] [Abstract][Full Text] [Related]
20. Induced interleukin-19 contributes to cell-mediated immunosuppression in patients undergoing coronary artery bypass grafting with cardiopulmonary bypass.
Yeh CH; Cheng BC; Hsu CC; Chen HW; Wang JJ; Chang MS; Hsing CH
Ann Thorac Surg; 2011 Oct; 92(4):1252-9. PubMed ID: 21855850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
